Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-25 @ 8:31 PM
NCT ID: NCT00654069
Description: None
Frequency Threshold: 5
Time Frame: 48 hours
Study: NCT00654069
Study Brief: Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Acurox 7.5/30 oxycodone 7.5mg/niacin 30mg 0 None 0 134 117 134 View
Placebo Placebo Pill 0 None 0 136 51 136 View
Acurox 5/30 oxycodone 5mg/niacin 30mg 0 None 0 135 104 135 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Flushing SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (10.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
Pruritis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (10.0) View